A complete application in a minute — tailored resume and cover letter, ready to send.
MoonLake Immunotherapeutics is seeking a Director of Marketing US to shape and execute peer-to-peer and HCP promotional strategies. The role drives launch readiness, omnichannel activation, and cross-functional alignment with agencies to deliver compliant, impactful programs across the US market.
The ideal candidate has 8+ years in biopharma, strong leadership, and a track record translating clinical data into compelling value stories, with deep FDA regulatory knowledge and agency management
The Director Marketing US will contribute to the development and execution of the US peer to peer and healthcare professional promotional strategy, translating brand strategy, clinical data, customer insights, and market dynamics into compelling, compliant HCP engagement plans. This role is accountable for driving launch readiness and in-market execution across core promotional channels, including personal and non-personal promotion, omnichannel activation, and peer to peer education, while partnering cross-functionally and with external agencies to ensure strategic alignment, operational excellence, and measurable business impact.
The Director Marketing US will contribute to the development and execution of the US peer to peer and healthcare professional promotional strategy, translating brand strategy, clinical data, customer insights, and market dynamics into compelling, compliant HCP engagement plans. This role is accountable for driving launch readiness and in-market execution across core promotional channels, including personal and non-personal promotion, omnichannel activation, and peer to peer education, while partnering cross-functionally and with external agencies to ensure strategic alignment, operational excellence, and measurable business impact.
An exciting job opportunity awaits you! MoonLake is a dynamic and innovative company pushing the boundaries of possibility, and we are looking for passionate individuals to join our stellar team.
MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of sonelokimab, a novel investigational Nanobody® for the treatment of the inflammatory disease, to revolutionize outcomes for patients. We continue to make significant progress in our Global Clinical Development Programs. The company’s focus is on inflammatory diseases with a major unmet need, including hidradenitis suppurativa and psoriatic arthritis – conditions affecting millions of people worldwide with a large need for improved treatment options. MoonLake was founded in 2021 and is headquarted in Zug, with hubs in Cambridge & Porto.
Further information is available at www.moonlaketx.com